News

At NGM, we pride ourselves on conducting world-class science and sharing our research efforts with the broader scientific and medical communities.

Select section

Jul 18, 2013

NGM Biopharmaceuticals Secures $50 Million in Series C Financing to Advance its Portfolio of Novel Therapies for Diabetes and Obesity

Read more View PDF

Jul 17, 2013

NGM Biopharmaceuticals and MedImmune, AstraZeneca’s Biologics Arm, Announce Agreement to Discover and Develop Therapies for Diabetes and Obesity

Read more View PDF

Jan 03, 2013

NGM Enters Agreement With Janssen to Discover and Develop Novel Therapeutics for Diabetes

Read more View PDF